300357 我武生物
按盤價 
20.010 -1.930 (-8.797%)
20.010 -1.930 (-8.797%) | 2026/06 - 中期 | 2025/12 | 2024/12 | 2023/12 | 2022/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | 7.944 | 15.320 | 14.005 | 14.896 | 18.773 |
| 總資產報酬率 ROA (%) | 7.144 | 13.589 | 12.059 | 13.033 | 16.890 |
| 投入資產回報率 ROIC (%) | 7.889 | 15.103 | 13.573 | 14.421 | 18.506 | 邊際利潤分析 |
| 銷售毛利率 (%) | 95.293 | 95.239 | 95.158 | 95.262 | 95.393 |
| 營業利潤率 (%) | 47.478 | 41.267 | 39.887 | 40.672 | 44.219 |
| 息稅前利潤/營業總收入 (%) | 45.067 | 38.579 | 36.157 | 37.312 | 41.799 |
| 淨利潤/營業總收入 (%) | 40.566 | 34.647 | 32.887 | 34.841 | 37.469 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 87.810 | 98.657 | 94.994 | 96.618 | 102.515 |
| 價值變動淨收益/利潤總額(%) | 13.453 | 1.421 | 1.772 | 0.360 | 0.676 |
| 營業外收支淨額/利潤總額(%) | -1.528 | -1.320 | -1.109 | 0.284 | 0.637 | 償債能力分析 |
| 流動比率 (X) | 9.142 | 12.182 | 9.045 | 8.867 | 14.376 |
| 速動比率 (X) | 8.875 | 11.804 | 8.729 | 8.534 | 13.905 |
| 資產負債率 (%) | 7.709 | 6.408 | 9.239 | 10.088 | 7.769 |
| 帶息債務/全部投入資本 (%) | -0.747 | -0.839 | -0.639 | 0.467 | -1.137 |
| 股東權益/帶息債務 (%) | -13,289.600 | -11,836.684 | -15,316.149 | 20,537.318 | -8,595.943 |
| 股東權益/負債合計 (%) | 1,160.706 | 1,410.804 | 940.372 | 845.429 | 1,159.304 |
| 利息保障倍數 (X) | -26.565 | -17.945 | -10.984 | -10.734 | -15.460 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 67.717 | 53.579 | 57.571 | 66.650 | 65.734 |
| 存貨周轉天數 (天) | 399.886 | 400.307 | 469.069 | 481.237 | 445.498 |
| 備註： | 報價延遲最少15分鐘，資料更新時間為 09/09/2026 16:30 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
